Given a significant role of VEGFR-2/VEGFR-3 in tumor development and progression, inhibition of both VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 signals has shown promising results in suppressing tumor progression and metastasis in preclinical studies [11]. Here, FLT4 is linked to neoplasm.